Advertisement
Having a cold or the flu may sometimes trigger a stroke in children -- particularly those with underlying health conditions -- though the overall risk remains low

Colds, Flu Up Odds for Stroke in Children, Though Risk Is Low

0
Researchers also found children who had all of their vaccinations were less vulnerable
Two experimental drugs

Two Experimental Drugs Promising for Psoriasis Rx

0
Targeted therapies produce significant results, researchers say
Women who start hormone therapy toward the beginning of menopause may have a lower risk of developing coronary heart disease

Earlier HRT May Pose Lower CHD Risk for Menopausal Women

0
Starting treatment around onset of menopause seems to lower threat to heart
Routine use of dual antiplatelet therapy beyond six months after second generation drug-eluting stent implantation yields mixed clinical results

Long Duration Dual Antiplatelet Treatment Increases Bleeding

0
However, leads to small decrease in stent thrombosis, myocardial infarction after stent
Two newer classes of drugs

Angioedema Induced by New Classes of Drugs

0
Angioedema occurs with DPP IV or neprilysin blockers; bradykinin contribution seems likely
Adjuvant aripiprazole is associated with achievement of remission among older adults with treatment-resistant depression

Adjuvant Aripiprazole Beneficial in Tx-Resistant Depression

0
Addition of aripiprazole effective for achieving remission in adults aged older than 60 years
Extra calcium may not protect aging bones after all. The findings appear online in two reviews published online Sept. 29 in The BMJ.

Calcium Supplements May Not Benefit Bone Health

0
Researchers find no evidence that increasing intake will prevent fractures
In a recent study

New Treatment Option for Some With Metastatic Lung Cancer

0
Nivolumab found most effective in tumors expressing programmed death-ligand 1
Daily aspirin might extend survival for patients with cancers of the gastrointestinal tract

More Evidence Daily Aspirin May Protect Against GI Cancer

0
Four-year study found survival doubled for GI cancer patients who took low-dose pill each day
In a new study

Novel Immunotx Shows Promise Against Advanced Renal Cancer

0
Nivolumab appears to outperform everolimus in new clinical trial